Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr958 Inhibitors

Olfr958, part of the olfactory receptor family 1 subfamily K, is a key player in the olfactory system of Mus musculus, serving as a G-protein-coupled receptor (GPCR). These receptors are vital in sensing and transducing odorant signals, leading to the perception of smell. Olfr958 features a typical GPCR structure with a 7-transmembrane domain, enabling it to bind to odorant molecules and activate intracellular signaling pathways. This specific binding and signal transduction capability is critical for the olfactory system's ability to recognize a wide range of scents, highlighting the importance of Olfr958 in olfactory perception. Inhibiting Olfr958's function can be achieved through direct or indirect methods. Direct inhibition involves blocking the receptor's interaction with odorant molecules, thereby preventing G-protein activation and subsequent signaling. This requires a high degree of molecular specificity to avoid off-target effects on other GPCRs. In contrast, indirect inhibition strategies involve modifying the receptor's membrane environment or targeting downstream signaling pathways or regulatory mechanisms. Altering membrane composition or receptor conformation can impact the receptor's ability to bind ligands or activate G-proteins, while influencing pathways that regulate receptor desensitization, internalization, or recycling can modulate its activity. The chemicals listed in the table represent potential indirect inhibitors of Olfr958, acting through various mechanisms such as cytochrome P450 enzyme inhibition, modulation of neurotransmitter receptors, or alteration of G-protein coupling efficiency. Understanding the mechanisms of Olfr958's function and inhibition is crucial for unraveling the complex dynamics of olfactory transduction. Both direct and indirect inhibition strategies provide insights into the modulation of GPCR activity, particularly in the context of olfactory receptors. This knowledge advances our understanding of olfactory perception and contributes to the broader field of GPCR research, which has significant implications in sensory biology and pharmacology. The study of inhibitors of Olfr958 and similar receptors is essential for developing a comprehensive understanding of the molecular dynamics governing olfactory signaling and exploring the potential for targeted modulation of these processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sotalol hydrochloride

959-24-0sc-203699
sc-203699A
10 mg
50 mg
$67.00
$246.00
3
(1)

Sotalol, an antiarrhythmic agent, can influence GPCR function due to its beta-blocker properties. This can lead to indirect modulation of GPCR signaling pathways, potentially affecting Olfr958.

Imipramine hydrochloride

113-52-0sc-207753
sc-207753B
sc-207753A
100 mg
1 g
5 g
$25.00
$44.00
$101.00
5
(1)

Imipramine, a tricyclic antidepressant with histamine and serotonin antagonist properties, affects GPCR modulation. This can indirectly impact the signaling of receptors like Olfr958 by altering the GPCR milieu.

Labetalol

36894-69-6sc-484723
50 mg
$176.00
(0)

Labetalol, a mixed alpha/beta adrenergic antagonist, modulates GPCR signaling pathways. Its action on both alpha and beta receptors can indirectly affect the signaling of GPCRs like Olfr958.

Lansoprazole

103577-45-3sc-203101
sc-203101A
500 mg
1 g
$58.00
$173.00
6
(0)

Lansoprazole, a proton pump inhibitor, can indirectly modulate GPCR activity. By influencing gastric acid secretion, it impacts the histamine-mediated modulation of GPCRs, potentially affecting Olfr958 signaling.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol, a non-selective beta-adrenergic receptor blocker, modulates GPCR signaling pathways indirectly. Its action on beta receptors can affect G-protein coupling in related GPCRs, potentially impacting Olfr958.

Verapamil

52-53-9sc-507373
1 g
$367.00
(0)

Verapamil, a calcium channel blocker, can influence GPCR function indirectly. By modulating calcium influx, it affects GPCR-mediated signaling, potentially impacting receptors like Olfr958.